Research and Innovation (R&I) plays a vital role in building on our understanding about the role of genomics in the onset, progression, heritability and treatment of disease.  It also helps in the discovery, development and validation of new genomic tests and personalised treatments, so that they can be used in routine clinical practice in the NHS.

Key Priorities

A key element of the NHS Genomics Strategy (2022) is to evolve the service through cutting-edge science, research and innovation to ensure that patients can benefit from rapid implementation of advances on a national scale, in alignment with national research aims.

This is supported by 3 national priorities:

  • Enabling patients to make informed choices on the use of their data for R&I.
  • Enriching existing and developing new NHS GMS relationships to support innovation and the generation of evidence for adoption and improvements in health and care.
  • Ensuring ongoing alignment with clinical trials and national life sciences projects and supporting the growth of life sciences in the UK.

 

Our Collaborative Approach 

The NEY GMS aims to be demonstrably research active, collaborating across NHS organisations, academia and industry to support development and delivery of high quality R&I that improves outcomes for patients and their families.

We’re committed to working with Genomics England, the National Institute for Health and Care Research (NIHR) and other partners to support genomic R&I projects across the region.

To develop and deliver our vision, the NEY GMS has developed an operating model and established a representative R&I Steering Group. See our Operating Model (Fig.1) 

Fig.1. NEY GMS Research & Innovation Operating Model

Primary Objectives

Working with our partners, we will develop and deliver a programme of work, aligned with key national priorities, to ensure that our local population can benefit from rapid implementation of advances in genomic medicine.

During 2024 and beyond, we will focus on the following areas:

  • Work with NHS GMS and key regional and national partners – develop our objectives and establish GMS R&I regional capacity and capability
  • Align with broader national research initiatives and pilots – contribute to key national NHS genomic programmes and relevant NIHR portfolio studies
  • Generation Study – lead regional delivery of the study in partnership with NHS recruiting sites
  • Genomic Networks of Excellence – support delivery of the GNoE programme and facilitate partnerships to translate genomic research and innovation discoveries, tools and approaches into NHS service delivery.

Programme Lead:

Dr Steven Pratt, NEY GMS Research & Innovation Director (click here to read more about Steven)

How can I learn more?

Contact us to learn more

[email protected]

Programme Lead:

Dr Steven Pratt, NEY GMS Research & Innovation Director